Sign In
Buy CSII
$20.00
+0 (+0%)
At Close: Jul 26, 2023
Cytek Biosciences Set to Join S&P SmallCap 600
05:54pm, Tuesday, 25'th Apr 2023
NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Mo
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
10:40am, Wednesday, 05'th Apr 2023
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
04:05pm, Monday, 03'rd Apr 2023
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients wi
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cardiovascul
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes
11:28am, Monday, 20'th Mar 2023
Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII).
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
04:57pm, Wednesday, 15'th Feb 2023
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSII
07:41pm, Monday, 13'th Feb 2023
NEW YORK , Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm ra
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cardiovascul
Abbott Buying Cardiovascular Systems: Details (ABT)
03:15pm, Friday, 10'th Feb 2023
Abbott (NYSE: ABT) is buying Cardiovascular Systems (CSI). These are the details.
Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss
10:32am, Friday, 10'th Feb 2023
With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance.
SHAREHOLDER ALERT: Weiss Law Investigates Cardiovascular Systems, Inc.
07:31pm, Thursday, 09'th Feb 2023
NEW YORK , Feb. 9, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cardiovascular Systems, Inc. ("Cardiov
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Cardiovascular Systems, Inc. Buyout
04:48pm, Thursday, 09'th Feb 2023
Wilmington, Delaware--(Newsfile Corp. - February 9, 2023) - Rigrodsky Law, P.A. is investigating Cardiovascular Systems, Inc. ("Cardiovascular") (NASDAQ: CSII) regarding possible breaches of fiduciary
Why Cardiovascular Systems Stock Is Soaring Today
11:59am, Thursday, 09'th Feb 2023
The medtech company has agreed to a buyout offer from Abbott Laboratories.
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
08:15am, Thursday, 09'th Feb 2023
Cardiovascular Systems (NASDAQ: CSII ) stock is rising higher on Thursday following news that Abbott (NYSE: ABT ) intends to acquire the company. That deal has Abbott offering to buy Cardiovascular Sy
CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders
07:13am, Thursday, 09'th Feb 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cardiovascular Systems, Inc. (NASDAQ: CSII) to Abbott Laboratories for $20.00 per common
